Identification of <i>CD14</i> as a Potential Biomarker Relating to PANoptosis in Chronic Obstructive Pulmonary Disease.

Meanwhile, CD14 and IRF2 both tended to exhibit higher expression in late-stage COPD samples, although the differences did not reach statistical significance ( Figure 5D ).

also in 111,027 other papers